Related Experiment Video
Updated: Jul 16, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Health-Related Quality of Life in Pediatric Hepatic Glycogen Storage Disease: A Dual-Perspective Study
Oznur Aydin1, Selcuk Dagdelen2, Hasan Ozen3
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara 06100, Türkiye.
Insights
Children with hepatic glycogen storage diseases (GSDs) have reduced health-related quality of life (HRQoL) compared to healthy peers. Assessments from both children and parents reveal significant impacts on daily functioning and well-being.
Area of Science:
- Metabolic disorders
- Pediatric health
- Quality of life research
Background:
- Hepatic glycogen storage diseases (GSDs) are rare inherited metabolic disorders.
- Lifelong nutritional management and metabolic control are essential for GSDs.
- These management strategies may negatively impact health-related quality of life (HRQoL).
Purpose of the Study:
- To evaluate HRQoL in children with hepatic GSD using child and parent reports.
- To compare HRQoL findings with normative data.
- To explore associations between HRQoL and biochemical, anthropometric, and nutritional parameters.
Main Methods:
- Included 23 children with hepatic GSD and their parents.
- Assessed HRQoL using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale.
- Compared child and parent reports with normative data and analyzed associations using correlation analyses.
Main Results:
- Children with hepatic GSD reported significantly lower HRQoL scores than healthy children and those with other chronic diseases.
- Parents reported lower HRQoL scores than children, especially in psychosocial, social, and school functioning.
- Body composition and nutritional treatment burden correlated with certain HRQoL domains.
Conclusions:
- Children with hepatic GSD experience impaired HRQoL from both child and parent perspectives.
- Integrating HRQoL assessment into routine care can identify unmet needs.
- Individualized nutritional management may be improved by considering HRQoL.
Abstract:
Background/Objectives: Hepatic glycogen storage diseases (GSDs) are rare inherited metabolic disorders requiring lifelong nutritional management and strict metabolic control, which may adversely affect the health-related quality of life (HRQoL). This study aimed to evaluate the HRQoL in children with hepatic GSD using both child and parent reports, compare findings with normative data, and explore associations with biochemical, anthropometric, and nutritional management-related parameters. Methods: The study included 23 children with hepatic GSD and their parents. HRQoL was assessed using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale. Child and parent reports were compared with normative data for healthy and chronically ill children. Agreement between child and parent reports was evaluated with intraclass correlation coefficients, and exploratory associations between variables were assessed using partial Spearman correlation analyses. Results: Total and most subscale PedsQL scores reported by both children and parents were significantly lower than those of healthy peers and children with chronic diseases (p < 0.05). Parents reported lower HRQoL scores than children, particularly in psychosocial, social, and school functioning domains, with low to moderate agreement between reports. Exploratory analyses suggested that body composition and nutritional treatment burden indicators were correlated with selected HRQoL domains. Conclusions: Children with hepatic GSD experience impaired HRQoL from both child and parent perspectives. Integrating HRQoL assessment into routine clinical and nutritional follow-up may help identify unmet psychosocial and dietary support needs and support more individualized nutritional management in children with hepatic GSD.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment